Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 24;12(1):e050628.
doi: 10.1136/bmjopen-2021-050628.

Impact of COVID-19 restrictions on behavioural and psychological symptoms in home-dwelling people with dementia: a prospective cohort study (PAN.DEM)

Marie H Gedde  1   2 , Bettina S Husebo  2   3 , Ipsit V Vahia  4   5 , Janne Mannseth  6 , Maarja Vislapuu  2 , Mala Naik  7   8 , Line I Berge  2   9
Affiliations

Impact of COVID-19 restrictions on behavioural and psychological symptoms in home-dwelling people with dementia: a prospective cohort study (PAN.DEM)

Marie H Gedde et al. BMJ Open. .

Abstract

Objectives: To investigate the impact of the COVID-19 restrictions on behavioural and psychological symptoms of dementia (BPSD).

Design: Prospective cohort study (PAN.DEM) nested within the halted parent trial (LIVE@Home.Path).

Setting: Households in Norway immediate before and 6-9 weeks into the COVID-19 restrictions.

Participants: 104 dyads (persons with mild to moderate dementia aged ≥65 and their informal carers) completed both prepandemic and pandemic assessments, among 237 in the parent trial. Mini-Mental Status Examination score 15-26 or Functional Assessment Staging score 3-7 covered dementia severity.

Main outcome measures: Neuropsychiatric Inventory (NPI-12) total (range 0-144), psychosis (range 0-24), hyperactive behaviour (range 0-60) and mood subsyndrome (range 0-48) scores; Cornell Scale for Depression in Dementia (CSDD) total score (range 0-38).

Results: We found an overall increase in BPSD by NPI-12 total score comparing prepandemic to pandemic levels (median 16 IQR (4.5-29) to 20 (7-32.5), p=0.03) over a mean of 86 days (SD 19). NPI-12 total score worsened in 57 (55%) of people with dementia and was associated with postponed or averted contacts with healthcare professionals (logistic regression, OR 3.96, 95% CI 1.05 to 14.95). Psychosis subsyndrome levels increased (0 (0-3) to 0.5 (0-6), p=0.01) in 37 (36%) persons; this worsening was associated with partial insight (9.57, 1.14 to 80.71) and reduced informal carer contact (4.45, 1.01 to 19.71). Moreover, depressive symptoms increased as assessed by CSDD total score (5 (3-9) to 7 (4-12), p=0.01) and worsened for 56 (54%), which was inversely associated with psychotropic drugs on-demand (0.16, 0.03 to 0.75).

Conclusions: BPSD worsened during the first months of the COVID-19 restrictions, most pronounced for psychosis and depression. These BPSD exacerbations have implications for pandemic policies, emphasising that restrictions must balance COVID-19 morbidity and mortality against dementia deterioration.

Trial registration number: NCT04043364; Results.

Keywords: COVID-19; dementia; health policy; old age psychiatry; primary care.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: MHG, MV, JM and LIB had financial support from the Research Council of Norway (grant number 273581), for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; IVV reports receiving honorarium as editor of the American Journal of Geriatric Psychiatry.

Figures

Figure 1
Figure 1
The parent trial, LIVE@Home.Path, including PAN.DEM. The COVID-19 restrictions replaced trial protocol from 12 March to eased on 15 May 2020. None of the dyads (person with dementia and informal carer, n) received the intervention while the PAN.DEM interviews were conducted (20 April 2020 to 15 May 2020). (A) Timeline. Vertical lines indicate assessments. The shaded parts illustrate the COVID-19 restrictions, postponing the Learning, Innovation, Volunteers and Empowerment (LIVE-Intervention) for the dyads of group 2. (B) Flow chart. This study includes the dyads of PAN.DEM completing the prepandemic assessment before the COVID-19 restrictions was implemented on 12 March 2020. *Parent trial attrition: rate within assumptions of lost to follow-up.
Figure 2
Figure 2
Change in behavioural and psychological symptoms in n (%) persons with dementia from the prepandemic to the pandemic assessment. n: 104. Prepandemic: Six-month assessment of parent trial (12 December 2019 to 11 March 2020). Pandemic: PAN.DEM assessment (20 April 2020 to 15 May 2020). Neuropsychiatric Inventory, subsyndrome score: psychosis (delusions and hallucinations), hyperactive behaviour (agitation, euphoria, irritation, disinhibition, aberrant motor behaviour), mood (depression, apathy, sleep disturbances and appetite changes). Cornell Scale for Depression in Dementia, total score.
See this image and copyright information in PMC

References

    1. Atkins JL, Masoli JAH, Delgado J, et al. . Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank community cohort. J Gerontol A Biol Sci Med Sci 2020;75:2224–30. 10.1093/gerona/glaa183 - DOI - PMC - PubMed
    1. Suárez-González A, Livingston G, Low L-F. Impact and mortality of COVID-19 on people living with dementia: cross-country report, 19 August 2020. Available: https://ltccovid.org/wp-content/uploads/2020/08/International-report-on-... [Accessed Aug 2021].
    1. Islam N, Sharp SJ, Chowell G, et al. . Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. BMJ 2020;370:m2743. 10.1136/bmj.m2743 - DOI - PMC - PubMed
    1. Wang H, Li T, Barbarino P, et al. . Dementia care during COVID-19. Lancet 2020;395:1190–1. 10.1016/S0140-6736(20)30755-8 - DOI - PMC - PubMed
    1. World Health Organization . Mental health and psychosocial considerations during the COVID-19 outbreak. Available: https://apps.who.int/iris/handle/10665/331490 [Accessed 18 Mar 2020].

Associated data